Back to Journals » International Journal of Nanomedicine » Volume 10 » Issue 1

Design and activity of a cyclic mini-β-defensin analog: a novel antimicrobial tool

Authors Scudiero O, Nigro E, Cantisani M, Colavita I, Leone M, Mercurio F, Galdiero M, Pessi A, Daniele A, Salvatore F, Galdiero S

Received 30 May 2015

Accepted for publication 23 July 2015

Published 15 October 2015 Volume 2015:10(1) Pages 6523—6539


Checked for plagiarism Yes

Review by Single-blind

Peer reviewers approved by Dr Preety Sahdev

Peer reviewer comments 4

Editor who approved publication: Prof. Dr. Thomas J Webster

Olga Scudiero,1,2 Ersilia Nigro,1 Marco Cantisani,3 Irene Colavita,1 Marilisa Leone,4 Flavia Anna Mercurio,4 Massimiliano Galdiero,5 Antonello Pessi,1 Aurora Daniele,1,6 Francesco Salvatore,1,2,7 Stefania Galdiero3,4

1CEINGE-Biotecnologie Avanzate Scarl, Naples, Italy; 2Dipartimento di Medicina Molecolare e Biotecnologie Mediche, 3Dipartimento di Farmacia, Università di Napoli Federico II, Naples, Italy; 4Istituto di Biostrutture e Bioimmagini, CNR, Naples, Italy; 5Dipartimento di Medicina Sperimentale, Seconda Università di Napoli, Naples, Italy; 6Dipartimento di Scienze e Tecnologie Ambientali Biologiche Farmaceutiche, Seconda Università di Napoli, Caserta, Italy; 7IRCCS Fondazione SDN, Naples, Italy

Abstract: We have designed a cyclic 17-amino acid β-defensin analog featuring a single disulfide bond. This analog, designated “AMC” (ie, antimicrobial cyclic peptide), combines the internal hydrophobic domain of hBD1 and the C-terminal charged region of hBD3. The novel peptide was synthesized and characterized by nuclear magnetic resonance spectroscopy. The antimicrobial activities against gram-positive and gram-negative bacteria as well as against herpes simplex virus type 1 were analyzed. The cytotoxicity and serum stability were assessed. Nuclear magnetic resonance of AMC in aqueous solution suggests that the structure of the hBD1 region, although not identical, is preserved. Like the parent defensins, AMC is not cytotoxic for CaCo-2 cells. Interestingly, AMC retains the antibacterial activity of the parent hBD1 and hBD3 against Pseudomonas aeruginosa, Enterococcus faecalis, and Escherichia coli, and exerts dose-dependent activity against herpes simplex virus type 1. Moreover, while the antibacterial and antiviral activities of the oxidized and reduced forms of the parent defensins are similar, those of AMC are significantly different, and oxidized AMC is also considerably more stable in human serum. Taken together, our data also suggest that this novel peptide may be added to the arsenal of tools available to combat antibiotic-resistant infectious diseases, particularly because of its potential for encapsulation in a nanomedicine vector.

Keywords: antimicrobial activity, cyclic mini-peptide, human beta-defensin

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]


Readers of this article also read:

Design and evaluation of an intravesical delivery system for superficial bladder cancer: preparation of gemcitabine HCl-loaded chitosan–thioglycolic acid nanoparticles and comparison of chitosan/poloxamer gels as carriers

Ay Şenyiğit Z, Karavana SY, İlem-Özdemir D, Çalışkan Ç, Waldner C, Şen S, Bernkop-Schnürch A, Baloğlu E

International Journal of Nanomedicine 2015, 10:6493-6507

Published Date: 14 October 2015

Development and evaluation of sunscreen creams containing morin-encapsulated nanoparticles for enhanced UV radiation protection and antioxidant activity

Shetty PK, Venuvanka V, Jagani HV, Chethan GH, Ligade VS, Musmade PB, Nayak UY, Reddy MS, Kalthur G, Udupa N, Rao CM, Mutalik S

International Journal of Nanomedicine 2015, 10:6477-6491

Published Date: 13 October 2015

In vivo biocompatibility of new nano-calcium-deficient hydroxyapatite/poly-amino acid complex biomaterials

Dai ZY, Li Y, Lu WZ, Jiang DM, Li H, Yan YG, Lv GY, Yang AP

International Journal of Nanomedicine 2015, 10:6303-6316

Published Date: 6 October 2015

Emerging and future therapies for hemophilia

Carr ME, Tortella BJ

Journal of Blood Medicine 2015, 6:245-255

Published Date: 3 September 2015

Methacrylic-based nanogels for the pH-sensitive delivery of 5-Fluorouracil in the colon

Ashwanikumar N, Kumar NA, Nair SA, Kumar GS

International Journal of Nanomedicine 2012, 7:5769-5779

Published Date: 15 November 2012

Cross-linked acrylic hydrogel for the controlled delivery of hydrophobic drugs in cancer therapy

Deepa G, Thulasidasan AK, Anto RJ, Pillai JJ, Kumar GS

International Journal of Nanomedicine 2012, 7:4077-4088

Published Date: 27 July 2012

Crystallization after intravitreal ganciclovir injection

Pitipol Choopong, Nattaporn Tesavibul, Nattawut Rodanant

Clinical Ophthalmology 2010, 4:709-711

Published Date: 14 July 2010